Hyperglycemia has been reported to be a risk factor for bladder cancer (BC). Enfortumab vedotin (EV), the first antibody-drug conjugates targeting NECTIN4, has shown promising clinical efficacy in pat
The rats were divided into two groups, irradiated group and non-irradiated group, with an irradiation dose of 17 Gy. The rats were sacrificed 4 months after irradiation, and the right lungs were obtai
